Keywords: bioscience, signs, euro, marketing, deal, signed, exclusive
US Bioscience Signs Euro Marketing Deal
Article | 17 July 1995
US Bioscience has signed an exclusive marketing and distribution agreement for two of its lead products, Hexalen (altretamine) and NeuTrexin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
